Amplitude for A/L = 0.29. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.338. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

Subjects:

Fig 5 - by Fatemeh Mohammadkhani (15927311)

20E repressed ILP-mediated cell membrane translocation of HaP60 and HaP110, dephosphorylated HaP60 and HaP110, and decreased their interaction. by Yu-Qin Di (8752317)

“…Insulin (5 μg/mL for 1 h); PBS as control of insulin; 20E (5 μM for 6 h); DMSO as control of 20E; TPI-1 (100 nM). …”

VAMP2 decreases 5-HT uptake and SERT cell surface expression in HEK-293 MSR cells by reducing the delivery rate of the transporter to the plasma membrane. by Heidi Kaastrup Müller (570207)

Decreased echinocandin susceptibility in <i>Candida parapsilosis</i> causing candidemia and emergence of a pan-echinocandin resistant case in China by Yating Ning (11264310)

Potassium depletion of Huh-7 cells results in a similar mitochondrial oxygen consumption rate and a moderately decreased extracellular acidification rate. by John W. Murray (2841077)

Representative gating strategy of SARS-CoV-2 peptide stimulated PBMC analysis by flow cytometry. by Katherine M. Littlefield (12647420)

Fig 5 - by Mykola Pinkevych (125551)

The primer information. by Guangxiao Ni (19713106)

Subjects:

Evans Blue extravasation between groups. by Guangxiao Ni (19713106)

Subjects:

Fibrosis markers. by Dwight D. Harris (14484648)

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

Decreased Na_v1.5 expression in <i>Scn5a</i>^+/− mice. by Anne-Laure Leoni (366926)

TUDCA decreases MPO with improved mitochondrial biogenesis, mitochondria-ER contact, and alveolar formation of HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

“…<p>(<b>A</b>) The increased MPO levels in HOX neonatal lungs are decreased by TUDCA treatment (0.1±0.1-fold; n = 6, p<0.05). …”

Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

PKI (inhibitor of PKA) prevented the high glucose-induced decrease of G6PD activity, prevented the high glucose-mediated increase in NOX activity, and prevented colocalization of G... by Zhaoyun Zhang (118032)

“…<p>A: Inhibition of PKA rescues the high glucose-induced decrease in G6PD activity. …”